Send us a link
Biden’s Moonshot Cancer Plan Calls for More Data Sharing
New report describes steps to double progress in 5 years
President Obama Pushes Innovation ‘Frontiers’ in STEM
More than $300M in new STEM initiatives were announced at the White House Frontiers Conference.
Harnessing the Possibilities of Science, Technology, and Innovation
President Obama Hosts Frontiers Conference, Focusing on the Potential of Science, Technology, and Innovation to Drive Prosperity and Address Challenges in Personal, Local, National, Global, and Interplanetary Frontiers for the Next 50 Years and Beyond.
Business Backs the Basics
Long-term basic research, substantially funded by the U.S. government, underlies some of industry's most profitable innovations.
Free to Collaborate with Cuban Biomedical Researchers
New rules also loosen restrictions on Cuban-made pharmaceuticals.
The Administration’s Report on the Future of AI
A new report from the US Administration focuses on the opportunities, considerations, and challenges of Artificial Intelligence (AI).
The boldness of philanthropists
Last week, Priscilla Chan and Mark Zuckerberg announced their new philanthropic initiative with the goal of “curing, preventing, and managing all diseases by the end of the century.” This may raise some eyebrows, but this effort—part of the $45 billion Chan Zuckerberg Initiative—joins forces with other philanthropists to push the envelope and support audacious ideas, with long-term commitments, to solve some of our greatest challenges.
Tougher rules for clinical-trial transparency
Investigators are now required to disclose all clinical trials, whether successful or not.
NIH aims to beef up clinical trial design
NIH wants to expand the sharing of summary data from clinical trials, such as test results being reviewed here at NIH’s clinical center.
Clinical trial rules aim to improve public reporting of results
Researchers will have to publicly report the results of many more clinical trials under new government rules announced Friday.
Research watchdog's new leader faces staff revolt
The new director of the federal office that guards against misconduct in U.S.-funded biomedical research is aiming to shake things up—but is also encountering rough waters. Kathryn Partin, who took the helm of the Office of Research Integrity (ORI) in December 2015, has launched a top-to-bottom review of the office, which has been criticized for moving too slowly and meting out sanctions that lack teeth.
Betting big on biomedical science
Ambitious bids in the US to map the brain and cure cancer have not boosted overall research funding.
Donald Trump's Lack of Respect for Science Is Alarming
The U.S. presidential election shows how far the political conversation has degenerated from the nation's founding principles of truth and evidence.
NSF tries two-step review, drawing praise—and darts
Thousands of conservation and environmental biologists must now survive two rounds of peer review before getting funding from the National Science Foundation (NSF). NSF says that the two-stage review process, which it launched 4 years ago as a pilot project in two divisions within its biology directorate, has resulted in a more manageable workload and fuller consideration of the highest-quality proposals.